CWA Asset Management Group LLC Raises Stock Position in DaVita Inc. (NYSE:DVA)

CWA Asset Management Group LLC raised its holdings in DaVita Inc. (NYSE:DVA) by 29.8% during the 4th quarter, Holdings Channel.com reports. The firm owned 3,518 shares of the company’s stock after acquiring an additional 808 shares during the period. CWA Asset Management Group LLC’s holdings in DaVita were worth $526,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Transcendent Capital Group LLC purchased a new stake in shares of DaVita in the third quarter worth about $25,000. Blue Trust Inc. boosted its position in DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after purchasing an additional 119 shares in the last quarter. Quarry LP acquired a new stake in shares of DaVita during the 3rd quarter worth approximately $60,000. Versant Capital Management Inc increased its holdings in shares of DaVita by 58.7% during the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $68,000 after purchasing an additional 169 shares in the last quarter. Finally, Point72 Hong Kong Ltd purchased a new stake in DaVita during the second quarter worth $68,000. 90.12% of the stock is owned by institutional investors and hedge funds.

DaVita Stock Up 0.7 %

Shares of NYSE DVA opened at $153.81 on Thursday. The firm has a market cap of $12.61 billion, a price-to-earnings ratio of 16.59, a price-to-earnings-growth ratio of 0.86 and a beta of 0.92. The company’s 50-day simple moving average is $155.13 and its 200-day simple moving average is $151.88. The company has a quick ratio of 1.33, a current ratio of 1.37 and a debt-to-equity ratio of 15.78. DaVita Inc. has a 52-week low of $103.40 and a 52-week high of $169.51.

DaVita (NYSE:DVA) last posted its quarterly earnings data on Tuesday, October 29th. The company reported $2.59 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.76 by ($0.17). The firm had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.25 billion. DaVita had a return on equity of 88.18% and a net margin of 6.53%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.85 earnings per share. Equities analysts predict that DaVita Inc. will post 9.71 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have weighed in on DVA shares. Barclays lifted their price objective on shares of DaVita from $150.00 to $164.00 and gave the company an “equal weight” rating in a report on Thursday, October 31st. Truist Financial upped their price target on DaVita from $165.00 to $175.00 and gave the stock a “hold” rating in a report on Monday, October 7th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $161.80.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.